These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 16557570)
1. Tumor lymphangiogenesis and metastatic spread-new players begin to emerge. Achen MG; Stacker SA Int J Cancer; 2006 Oct; 119(8):1755-60. PubMed ID: 16557570 [TBL] [Abstract][Full Text] [Related]
2. Molecular control of lymphatic metastasis. Achen MG; Stacker SA Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975 [TBL] [Abstract][Full Text] [Related]
3. IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma. Zhao W; Wang J; Zhu B; Duan Y; Chen F; Nian W; Sun J; Zhang B; Tong Z; Chen Z Oncol Rep; 2016 Mar; 35(3):1483-92. PubMed ID: 26706909 [TBL] [Abstract][Full Text] [Related]
4. Lymphangiogenic growth factors, receptors and therapies. Lohela M; Saaristo A; Veikkola T; Alitalo K Thromb Haemost; 2003 Aug; 90(2):167-84. PubMed ID: 12888864 [TBL] [Abstract][Full Text] [Related]
5. Tumor lymphangiogenesis and lymphangiogenic growth factors. Da MX; Wu Z; Tian HW Arch Med Res; 2008 May; 39(4):365-72. PubMed ID: 18375246 [TBL] [Abstract][Full Text] [Related]
16. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis. Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666 [TBL] [Abstract][Full Text] [Related]
17. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients. Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190 [TBL] [Abstract][Full Text] [Related]
18. Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer. Lala PK; Nandi P; Majumder M Cancer Metastasis Rev; 2018 Sep; 37(2-3):369-384. PubMed ID: 29858743 [TBL] [Abstract][Full Text] [Related]
19. The role of tumor lymphangiogenesis in metastatic spread. Stacker SA; Baldwin ME; Achen MG FASEB J; 2002 Jul; 16(9):922-34. PubMed ID: 12087053 [TBL] [Abstract][Full Text] [Related]
20. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model. Whitehurst B; Flister MJ; Bagaitkar J; Volk L; Bivens CM; Pickett B; Castro-Rivera E; Brekken RA; Gerard RD; Ran S Int J Cancer; 2007 Nov; 121(10):2181-91. PubMed ID: 17597103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]